1. A phase II multicenter trial assessing the efficacy and safety of first-line S-1 + ramucirumab in elderly patients with advanced/recurrent gastric cancer: KSCC1701. (May 2022) Authors: Kobayshi, Kazuma; Suyama, Koichi; Katsuya, Hiroo; Izawa, Naoki; Uenosono, Yoshikazu; Hu, Qingjiang; Kusumoto, Tetsuya; Otsu, Hajime; Orita, Hiroyuki; Kawanaka, Hirofumi; Shibao, Kazunori; Koga, Satoshi; Shimokawa, Mototsugu; Makiyama, Akitaka; Saeki, Hiroshi; Oki, Eiji; Baba, Hideo; Mori, Masaki Journal: European journal of cancer Issue: Volume 166(2022) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Detection of a pinhole‐sized bronchoesophageal fistula under bronchoscopic autofluorescence imaging. Issue 13 (18th May 2021) Authors: Morikawa, Kei; Izawa, Naoki; Kida, Hirotaka; Handa, Hiroshi; Inoue, Takeo; Mineshita, Masamichi Journal: Thoracic cancer Issue: Volume 12:Issue 13(2021) Page Start: 2043 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FMS‐like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer. Issue 1 (20th November 2020) Authors: Hasegawa, Hiroko; Taniguchi, Hiroya; Nakamura, Yoshiaki; Kato, Takeshi; Fujii, Satoshi; Ebi, Hiromichi; Shiozawa, Manabu; Yuki, Satoshi; Masuishi, Toshiki; Kato, Ken; Izawa, Naoki; Moriwaki, Toshikazu; Oki, Eiji; Kagawa, Yoshinori; Denda, Tadamichi; Nishina, Tomohiro; Tsuji, Akihito; Hara, Hiroki... Journal: Cancer science Issue: Volume 112:Issue 1(2021) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment. (7th February 2022) Authors: Mizukami, Takuro; Hamaji, Koki; Onuki, Risa; Yokomizo, Ayako; Nagashima, Yoshie; Takeda, Hiroyuki; Umemoto, Kumiko; Doi, Ayako; Arai, Hiroyuki; Hirakawa, Mami; Horie, Yoshiki; Izawa, Naoki; Ogura, Takashi; Tsuda, Takashi; Sunakawa, Yu; Shibata, Michi; Tanaka, Tsuneaki; Mikami, Shinya; Nakajima, T... Journal: Nutrition and cancer Issue: Volume 74:Number 2(2022) Page Start: 539 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The Molecular Landscape of Pancreatobiliary Cancers for Novel Targeted Therapies From Real-World Genomic Profiling. (18th May 2022) Authors: Umemoto, Kumiko; Yamamoto, Hiroyuki; Oikawa, Ritsuko; Takeda, Hiroyuki; Doi, Ayako; Horie, Yoshiki; Arai, Hiroyuki; Ogura, Takashi; Mizukami, Takuro; Izawa, Naoki; Moore, Jay A; Sokol, Ethan S; Sunakawa, Yu Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 9(2022) Page Start: 1279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗